WealthPlan Investment Management LLC Has $1.57 Million Position in Procter & Gamble Company (The) $PG

Key Points

• WealthPlan Investment Management LLC increased its holdings in Procter & Gamble by 395.6% to a total of 9,843 shares, valued at approximately $1.57 million.
• CEO Jon R. Moeller and COO Shailesh Jejurikar recently sold shares worth around $2.38 million combined, decreasing their ownership stake in the company.
• Procter & Gamble declared a quarterly dividend of $1.0568 per share, set to be paid on November 17th, with a 2.8% dividend yield.

WealthPlan Investment Management LLC increased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 395.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,843 shares of the company's stock after acquiring an additional 7,857 shares during the period. WealthPlan Investment Management LLC's holdings in Procter & Gamble were worth $1,568,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Variant Private Wealth LLC acquired a new position in Procter & Gamble in the second quarter valued at about $254,000. Callahan Advisors LLC boosted its position in Procter & Gamble by 2.0% in the second quarter. Callahan Advisors LLC now owns 106,094 shares of the company's stock valued at $16,903,000 after buying an additional 2,114 shares in the last quarter. Uptick Partners LLC boosted its position in Procter & Gamble by 7.4% in the second quarter. Uptick Partners LLC now owns 17,953 shares of the company's stock valued at $2,860,000 after buying an additional 1,243 shares in the last quarter. Keeler & Nadler Financial Planning & Wealth Management boosted its position in Procter & Gamble by 9.0% in the second quarter. Keeler & Nadler Financial Planning & Wealth Management now owns 1,303 shares of the company's stock valued at $208,000 after buying an additional 108 shares in the last quarter. Finally, Generali Asset Management SPA SGR boosted its position in Procter & Gamble by 2.8% in the second quarter. Generali Asset Management SPA SGR now owns 191,380 shares of the company's stock valued at $30,491,000 after buying an additional 5,125 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Jon R. Moeller sold 11,684 shares of the business's stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares of the company's stock, valued at $48,703,248.36. The trade was a 3.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Shailesh Jejurikar sold 3,986 shares of the company's stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the sale, the chief operating officer directly owned 46,899 shares of the company's stock, valued at $7,139,434.77. The trade was a 7.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 over the last 90 days. Company insiders own 0.20% of the company's stock.

Procter & Gamble Trading Up 1.4%

PG opened at $149.50 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company has a market cap of $349.90 billion, a price-to-earnings ratio of 22.96, a price-to-earnings-growth ratio of 3.91 and a beta of 0.36. The firm has a 50 day simple moving average of $154.96 and a 200 day simple moving average of $158.97. Procter & Gamble Company has a fifty-two week low of $146.96 and a fifty-two week high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble's payout ratio is 64.98%.

Analyst Upgrades and Downgrades

A number of research firms have commented on PG. Wells Fargo & Company reduced their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a research report on Thursday, September 25th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Evercore ISI reiterated an "in-line" rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Berenberg Bank upped their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a research report on Wednesday, September 17th. Finally, Barclays reduced their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a research report on Wednesday, October 1st. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of "Moderate Buy" and a consensus price target of $172.21.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.